EDWARD BALZER: Open Payments
NPI 1720763196 · MELVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,224 in 114 payments from 19 companies in 2025. Trend: 2023 $1,093 · 2024 $2,155 · 2025 $2,224
Food & beverage: $2,224
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $363 |
| Lundbeck LLC | 22 | $337 |
| Corium, LLC | 20 | $329 |
| Otsuka America Pharmaceutical, Inc. | 14 | $254 |
| E.R. Squibb & Sons, L.L.C. | 9 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $146 |
| Alkermes, Inc. | 6 | $116 |
| Axsome Therapeutics, Inc. | 1 | $115 |
| Collegium Pharmaceutical, Inc. | 5 | $93 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
Products named: VRAYLAR, ABILIFY ASIMTUFII, Azstarys, REXULTI, COBENFY, CAPLYTA, Auvelity, ARISTADA.
Industry payments across NY — which companies pay providers there.
